Several new surgical, endoscopic and pharmacological approaches to the management of digestive disorders have become available, yet their exact role in the management of these disorders is unclear. Providers need to recognize the range of therapeutic and diagnostic options that are now available for the management of digestive disorders and their clinical applications. This course will address the challenge of defining the role of new technologies, disease entities and therapies in everyday clinical practice by presenting the latest evidence-based information on diagnostics and therapeutics in digestive disorders.

TARGETED AUDIENCE

Physicians, physician assistants, nurse practitioners, nurses, residents/fellows, students, and researchers in gastroenterology, GI surgery, colorectal surgery, internal medicine, and hepatology.

EDUCATIONAL OBJECTIVES

Upon completion of this course audience members should be able to: 

• Counsel patients on the true risks and benefits of proton pump inhibitors
• Select the optimal treatment strategy for the patient with GERD and the patient with Barrett’s esophagus
• Describe the relative usefulness of the various approaches to colon cancer screening
• Define risk for surgery in the patient with cirrhosis and develop strategies to minimize them
• Describe current approaches to the management of pancreatic cancer
• Choose the best treatment options for patients with irritable bowel syndrome and ulcerative colitis
• Develop a logical approach to the patient with cholestasis and the patient with bile duct obstruction

ACCREDITATION

Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Houston Methodist designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.